Zobrazeno 1 - 8
of 8
pro vyhledávání: '"L. V. Kramskaya"'
Autor:
E. I. Kovalenko, E. V. Artamonova, L. V. Bolotina, L. A. Zhiliaeva, D. M. Ponomarenko, E. V. Karabina, G. Z. Mukhametshina, A. I. Khasanova, E. Yu. Ratner, A. R. Safarova, A. G. Manikhas, N. O. Popova, I. V. Evstigneeva, L. Yu. Vladimirova, L. V. Kramskaya, T. V. Karandeeva, I. R. Suslova, O. V. Romanchuk, V. E. Shikina, A. Yu. Povyshev, M. A. Osipov, E. M. Cherniakova, A. S. Dergunov, M. V. Volkonskiy, I. S. Chernov, I. E. Shumskaya, M. M. Fael, V. I. Garifullina, I. E. Gudkova
Publikováno v:
Медицинский совет, Vol 0, Iss 20, Pp 36-46 (2021)
Introduction. The standard of 1st line treatment of HER2+ metastatic breast cancer (mBC) is double blockade with trastuzumab and pertuzumab + taxane, 2nd line – Trastuzumab-emtazine. There are no standards for further treatment, as well as the opti
Externí odkaz:
https://doaj.org/article/ddfb182fcf6247f0b4a7bd188e53d850
Autor:
A. D. Kaprin, V. M. Khomyakov, D. D. Sobolev, L. V. Bolotina, A. B. Ryabov, V. E. Khoronenko, M. M. Soboleva, L. V. Kramskaya
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 2, Iss 4, Pp 17-27 (2016)
Purpose. Improvement of the results of treatment of patients with locally advanced and metastatic gastric cancer. Material and methods. From the 2010–2014 we performed 30 surgeries using techniques HICT. Among patients there were 17 men and 13 wome
Externí odkaz:
https://doaj.org/article/0b532890ac034a928b057c0f9a159ae1
Publikováno v:
Современная онкология, Vol 14, Iss 1, Pp 21-23 (2012)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::1b5c336598bb11b528d63850f019a1df
https://modernonco.orscience.ru/1815-1434/article/view/29472
https://modernonco.orscience.ru/1815-1434/article/view/29472
Autor:
L. V. Kramskaya, V. V. Cheremisov, D. D. Sobolev, A. V. Ivanov, L. V. Bolotina, V. M. Khomyakov, A. V. Chayka, Andrey Kaprin, A. B. Utkina, I. V. Kolobaev, A. B. Ryabov
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 5:12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b499a2ba94e4b0224e319e11a29b80f9
https://doi.org/10.17116/onkolog20165212-18
https://doi.org/10.17116/onkolog20165212-18
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 4:52
The paper considers current approaches to treating locally advanced and resectable gastric cancer. It gives the results of the largest studies dealing with adjuvant chemotherapy, chemoradiation treatment, perioperative chemotherapy for gastric cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a824896868fb3228316e6f40031a0586
https://doi.org/10.17116/onkolog20154452-56
https://doi.org/10.17116/onkolog20154452-56
Autor:
L. V. Kramskaya, I. V. Kolobaev, M. M. Shemetova, A. B. Utkina, L. V. Bolotina, A. B. Ryabov, V. M. Khomyakov, P. A. Herzen Moscow, Andrey Kaprin, P. A. Herzen, A. V. Ivanov, V. E. Khoronenko, D. D. Sobolev
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 4:67
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64f435f5adc96bf4b98c371c6a065c53
https://doi.org/10.17116/onkolog20154167-70
https://doi.org/10.17116/onkolog20154167-70
Autor:
V. E. Khoronenko, A. B. Ryabov, A. V. Ivanov, D. D. Sobolev, I. V. Kolobaev, L. V. Bolotina, Andrey Kaprin, V. M. Khomyakov, L. V. Kramskaya, M. M. Shemetova
Publikováno v:
Onkologiya. Zhurnal imeni P.A.Gertsena. 3:5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8ec712f3cdefe98e55a28b1168dba09
https://doi.org/10.17116/oncolog201465-12
https://doi.org/10.17116/oncolog201465-12
Autor:
E V Artamonova, E I Kovalenko, A V Snegovoy, A A Aksarin, T A Anciferova, A V Belonogov, E V Bilan, S N Bilenko, I M Varvus, E A Gorkovenko, R F Enikeev, A M Ermolaeva, L V Kramskaya, I B Kononenko, A P Pechenyy, S Z Safina, T V Chupriyanova, G G Chuhua, A I Shemyakina, E V Shikina
Publikováno v:
Современная онкология, Vol 20, Iss 3, Pp 19-25 (2018)
Background and aims. There is no data on olaparib efficacy and safety in Russian routine clinical practice. Methods. We analysed the 30 consecutive patients who received maintenance olaparib treatment for platinum-sensitive relapse (PSR) of ovarian o
Externí odkaz:
https://doaj.org/article/dd31107e3e054b2f8a0745e52e2e870d